Clinical and pathologic features of families with LRRK2-associated Parkinson’s disease

  • N. R. Whaley
  • R. J. Uitti
  • D. W. Dickson
  • M. J. Farrer
  • Z. K. Wszolek
Conference paper

DOI: 10.1007/978-3-211-45295-0_34

Part of the Journal of Neural Transmission. Supplementa book series (NEURALTRANS, volume 70)
Cite this paper as:
Whaley N.R., Uitti R.J., Dickson D.W., Farrer M.J., Wszolek Z.K. (2006) Clinical and pathologic features of families with LRRK2-associated Parkinson’s disease. In: Riederer P., Reichmann H., Youdim M.B.H., Gerlach M. (eds) Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa, vol 70. Springer, Vienna

Summary

The etiology for Parkinson’s disease (PD) remains unknown. Genetic causes have been identified with several distinct mutations. Recently, 9 mutations involving a novel gene, leucine-rich repeat kinase 2 (LRRK2), have been identified as the cause of autosomal dominant PD in kindreds, with some of them previously linked to the PARK8 locus on chromosome 12. LRRK2 mutations are relatively common genetic causes of familial and sporadic PD. In addition, these mutations have been identified in diverse populations. The clinical and pathologic features of LRRK2-associated PD are indistinguishable from idiopathic PD; however, considerable clinical and pathologic variability exists even among kindreds. This short review highlights the clinical and pathologic features in LRRK2-associated parkinsonism.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • N. R. Whaley
    • 1
  • R. J. Uitti
    • 1
  • D. W. Dickson
    • 2
  • M. J. Farrer
    • 2
  • Z. K. Wszolek
    • 1
  1. 1.Department of NeurologyMayo ClinicJacksonvilleUSA
  2. 2.Department of NeuroscienceMayo ClinicJacksonvilleUSA

Personalised recommendations